Constitutive NF-κB activation and tumor-growth promotion by Romo1-mediated reactive oxygen species production

Jin Sil Chung, Sora Lee, Young Do Yoo

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Deregulation of nuclear factor-κB (NF-κB) and related pathways contribute to tumor cell proliferation and invasion. Mechanisms for constitutive NF-κB activation are not fully explained; however, the underlying defects appear to generate and maintain pro-oxidative conditions. In hepatocellular carcinoma (HCC) tissues, up-regulation of reactive oxygen species modulator 1 (Romo1) correlates positively with tumor size. In the present study, we showed that Romo1 expression is required to maintain constitutive nuclear DNA-binding activity of NF-κB and transcriptional activity through constitutive IκBα phosphorylation. Overexpression of Romo1 promoted p65 nuclear translocation and DNA-binding activity. We also show that Romo1 depletion suppressed anchorage-independent colony formation by HCC cells and suppressed tumor growth in vivo. Based on these findings, Romo1 may be a principal regulatory factor in the maintenance of constitutive NF-κB activation in tumor cells. In the interest of anti-proliferative treatments for cancer, Romo1 may also present a productive target for drug development.

Original languageEnglish
Pages (from-to)1656-1661
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume450
Issue number4
DOIs
Publication statusPublished - 2014 Aug 8

Fingerprint

Modulators
Tumors
Reactive Oxygen Species
Chemical activation
Growth
Neoplasms
Hepatocellular Carcinoma
Phosphorylation
Deregulation
DNA
Cell proliferation
Up-Regulation
Cells
Maintenance
Cell Proliferation
Tissue
Defects
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Constitutive NF-κB activation and tumor-growth promotion by Romo1-mediated reactive oxygen species production. / Chung, Jin Sil; Lee, Sora; Yoo, Young Do.

In: Biochemical and Biophysical Research Communications, Vol. 450, No. 4, 08.08.2014, p. 1656-1661.

Research output: Contribution to journalArticle

@article{74438491202247ad85900ef00619a030,
title = "Constitutive NF-κB activation and tumor-growth promotion by Romo1-mediated reactive oxygen species production",
abstract = "Deregulation of nuclear factor-κB (NF-κB) and related pathways contribute to tumor cell proliferation and invasion. Mechanisms for constitutive NF-κB activation are not fully explained; however, the underlying defects appear to generate and maintain pro-oxidative conditions. In hepatocellular carcinoma (HCC) tissues, up-regulation of reactive oxygen species modulator 1 (Romo1) correlates positively with tumor size. In the present study, we showed that Romo1 expression is required to maintain constitutive nuclear DNA-binding activity of NF-κB and transcriptional activity through constitutive IκBα phosphorylation. Overexpression of Romo1 promoted p65 nuclear translocation and DNA-binding activity. We also show that Romo1 depletion suppressed anchorage-independent colony formation by HCC cells and suppressed tumor growth in vivo. Based on these findings, Romo1 may be a principal regulatory factor in the maintenance of constitutive NF-κB activation in tumor cells. In the interest of anti-proliferative treatments for cancer, Romo1 may also present a productive target for drug development.",
keywords = "Hepatocellular carcinoma, Nuclear factor-kappa B, Oxidative stress, Reactive oxygen species, Romo1, Tumor growth",
author = "Chung, {Jin Sil} and Sora Lee and Yoo, {Young Do}",
year = "2014",
month = "8",
day = "8",
doi = "10.1016/j.bbrc.2014.07.059",
language = "English",
volume = "450",
pages = "1656--1661",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "4",

}

TY - JOUR

T1 - Constitutive NF-κB activation and tumor-growth promotion by Romo1-mediated reactive oxygen species production

AU - Chung, Jin Sil

AU - Lee, Sora

AU - Yoo, Young Do

PY - 2014/8/8

Y1 - 2014/8/8

N2 - Deregulation of nuclear factor-κB (NF-κB) and related pathways contribute to tumor cell proliferation and invasion. Mechanisms for constitutive NF-κB activation are not fully explained; however, the underlying defects appear to generate and maintain pro-oxidative conditions. In hepatocellular carcinoma (HCC) tissues, up-regulation of reactive oxygen species modulator 1 (Romo1) correlates positively with tumor size. In the present study, we showed that Romo1 expression is required to maintain constitutive nuclear DNA-binding activity of NF-κB and transcriptional activity through constitutive IκBα phosphorylation. Overexpression of Romo1 promoted p65 nuclear translocation and DNA-binding activity. We also show that Romo1 depletion suppressed anchorage-independent colony formation by HCC cells and suppressed tumor growth in vivo. Based on these findings, Romo1 may be a principal regulatory factor in the maintenance of constitutive NF-κB activation in tumor cells. In the interest of anti-proliferative treatments for cancer, Romo1 may also present a productive target for drug development.

AB - Deregulation of nuclear factor-κB (NF-κB) and related pathways contribute to tumor cell proliferation and invasion. Mechanisms for constitutive NF-κB activation are not fully explained; however, the underlying defects appear to generate and maintain pro-oxidative conditions. In hepatocellular carcinoma (HCC) tissues, up-regulation of reactive oxygen species modulator 1 (Romo1) correlates positively with tumor size. In the present study, we showed that Romo1 expression is required to maintain constitutive nuclear DNA-binding activity of NF-κB and transcriptional activity through constitutive IκBα phosphorylation. Overexpression of Romo1 promoted p65 nuclear translocation and DNA-binding activity. We also show that Romo1 depletion suppressed anchorage-independent colony formation by HCC cells and suppressed tumor growth in vivo. Based on these findings, Romo1 may be a principal regulatory factor in the maintenance of constitutive NF-κB activation in tumor cells. In the interest of anti-proliferative treatments for cancer, Romo1 may also present a productive target for drug development.

KW - Hepatocellular carcinoma

KW - Nuclear factor-kappa B

KW - Oxidative stress

KW - Reactive oxygen species

KW - Romo1

KW - Tumor growth

UR - http://www.scopus.com/inward/record.url?scp=84906089429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906089429&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2014.07.059

DO - 10.1016/j.bbrc.2014.07.059

M3 - Article

VL - 450

SP - 1656

EP - 1661

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 4

ER -